GSK's shingles vaccine approved for use in China in adults aged 50 and above
GlaxoSmithKline Plc said on Thursday its shingles vaccine had been approved for use in China in adults aged 50 and above.
from Reuters: Health News https://reut.rs/2HSxTip
http://bit.ly/2zwRqiM
May 23, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on May 23, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.